| abstract |
The invention discloses biomarkers for detecting lung cancer and lung cancer prognosis, which comprise any combination of SLITRK6, NIPAL4, DPPA2, ID1, STK24, ARL2BP, MYEOV, MME, CRYBB1, RETN, LRIF1, EPG5, COX16, PTCD1, C8B and UFD 1L. The biomarkers have higher accuracy, sensitivity and specificity in diagnosing cancer in different models. And the biomarkers can effectively predict the prognosis of the patient. |